Limit search to available items
Nearby Subjects are:
Result Page   Prev Next
Add Marked to Bag Add All On Page Add Marked to My Lists
Mark   Year Entries
 

Immunotherapies, Adoptive -- See Immunotherapy, Adoptive


Form of adoptive transfer where cells with antitumor activity are transferred to the tumor-bearing host in order to mediate tumor regression. The lymphoid cells commonly used are lymphokine-activated killer (LAK) cells and tumor-infiltrating lymphocytes (TIL). This is usually considered a form of passive immunotherapy. (From DeVita, et al., Cancer, 1993, pp.305-7, 314)
  1
 

Immunotherapies, Adoptive Cellular -- See Immunotherapy, Adoptive


Form of adoptive transfer where cells with antitumor activity are transferred to the tumor-bearing host in order to mediate tumor regression. The lymphoid cells commonly used are lymphokine-activated killer (LAK) cells and tumor-infiltrating lymphocytes (TIL). This is usually considered a form of passive immunotherapy. (From DeVita, et al., Cancer, 1993, pp.305-7, 314)
  1
 

Immunotherapies, Allergen -- See Desensitization, Immunologic


Immunosuppression by the administration of increasing doses of antigen. Though the exact mechanism is not clear, the therapy results in an increase in serum levels of allergen-specific IMMUNOGLOBULIN G, suppression of specific IgE, and an increase in suppressor T-cell activity
  1
 

Immunotherapies, Passive -- See Immunization, Passive


Transfer of immunity from immunized to non-immune host by administration of serum antibodies, or transplantation of lymphocytes (ADOPTIVE TRANSFER)
  1
  Immunotherapy -- 3 Related Subjects   3
Immunotherapy.   125
Immunotherapy, Active   10
Immunotherapy, Active -- methods : Immunologic adjuvant research / Antonio H. Benvenuto, editor  2009 1
Immunotherapy, Adoptive   4
 

Immunotherapy, Adoptive Cellular -- See Immunotherapy, Adoptive


Form of adoptive transfer where cells with antitumor activity are transferred to the tumor-bearing host in order to mediate tumor regression. The lymphoid cells commonly used are lymphokine-activated killer (LAK) cells and tumor-infiltrating lymphocytes (TIL). This is usually considered a form of passive immunotherapy. (From DeVita, et al., Cancer, 1993, pp.305-7, 314)
  1
Immunotherapy, Adoptive -- methods   2
Immunotherapy -- adverse effects : Handbook of cancer treatment-related toxicities / Vamsi Velcheti, Salman R. Punekar  2022 1
 

Immunotherapy, Allergen -- See Desensitization, Immunologic


Immunosuppression by the administration of increasing doses of antigen. Though the exact mechanism is not clear, the therapy results in an increase in serum levels of allergen-specific IMMUNOGLOBULIN G, suppression of specific IgE, and an increase in suppressor T-cell activity
  1
Allergy -- Immunotherapy   7
Asthma -- Immunotherapy.   2
Autoimmune diseases -- Immunotherapy   3
Brain -- Tumors -- Immunotherapy   3
Cancer -- Immunotherapy.   76
Cancer -- Immunotherapy -- Complications   2
Cancer -- Immunotherapy -- Congresses : Policy Issues in the Clinical Development and Use of Immunotherapy for Cancer Treatment : Proceedings of a Workshop  1969 1
Cancer -- Immunotherapy -- Laboratory manuals   2
Cancer -- Immunotherapy -- Periodicals   2
Cancer -- Immunotherapy -- Research : Successes and Challenges of NK Immunotherapy Breaking Tolerance to Cancer Resistance  2021 1
Immunotherapy -- Complications. : Managing immunotherapy related organ toxicities : a practical guide / Yinghong Wang, editor  2022 1
Immunotherapy -- Congresses : Immunotherapy in 2020 : visions and trends for targeting inflammatory disease / A. Radbruch [and others], editors  2007 1
Diabetes -- Immunotherapy -- Congresses. : Defining optimal immunotherapies for type 1 diabetes  2008 1
Digestive organs -- Cancer -- Immunotherapy : Immunotherapy for gastrointestinal malignancies / Ramakrishna Vadde, Ganji Purnachandra Nagaraju, editors  2020 1
Immunotherapy -- ethics : New treatments for addiction : behavioral, ethical, legal, and social questions / Committee on Immunotherapies and Sustained-Release formations for Treating Drug Addiction ; Henrick J. Harwood and Tracy G. Myers, editors  2004 1
Gastrointestinal system -- Cancer -- Immunotherapy   3
Genitourinary organs -- Cancer -- Immunotherapy : Neoadjuvant immunotherapy treatment of localized genitourinary cancers : multidisciplinary management / Andrea Necchi, Philippe E. Spiess, editors  2022 1
Gliomas -- Immunotherapy   2
Immunotherapy -- Handbooks, manuals, etc   2
Head -- Cancer -- Immunotherapy : Immunotherapy for head and neck cancer / Anthony T. C. Chan, Brigette B.Y. Ma, editors  2023 1
HIV infections -- Immunotherapy : Soluble factors mediating innate immune responses to HIV infection / edited by Massimo Alfano  2010 1
Infertility, Female -- Immunotherapy : Lymphocyte immunization therapy (LIT) in reproductive failures : new horizons / Mohan Raut, Mugdha Raut  2022 1
Immunotherapy -- legislation & jurisprudence : New treatments for addiction : behavioral, ethical, legal, and social questions / Committee on Immunotherapies and Sustained-Release formations for Treating Drug Addiction ; Henrick J. Harwood and Tracy G. Myers, editors  2004 1
Lungs -- Cancer -- Immunotherapy : EGFR-directed therapy in lung cancer / So Yeon Kim, Daniel B. Costa, Daisuke Shibahara, Susumu Kobayashi, Balazs Halmos  2023 1
Medical mycology -- Immunotherapy : Antifungal Agents : Methods and Protocols  2006 1
Melanoma -- Immunotherapy. : M-VAX TM - a treatment for patients with advanced stage III melanoma : assessment report  2002 1
Immunotherapy -- Methods   40
Multiple sclerosis -- Immunotherapy   2
Mycoses -- Immunotherapy : Antifungal agents : methods and protocols / edited by Erika J. Ernst and P. David Rogers  2005 1
Neck -- Cancer -- Immunotherapy : Immunotherapy for head and neck cancer / Anthony T. C. Chan, Brigette B.Y. Ma, editors  2023 1
Nervous system -- Diseases -- Immunotherapy : Immunotherapy and biomarkers in neurodegenerative disorders / edited by Martin Ingelsson and Lars Lannfelt  2016 1
 

Immunotherapy, Passive -- See Immunization, Passive


Transfer of immunity from immunized to non-immune host by administration of serum antibodies, or transplantation of lymphocytes (ADOPTIVE TRANSFER)
  1
Immunotherapy -- Periodicals   21
Sarcoma -- Immunotherapy : Immunotherapy of sarcoma / Sandra P. D'Angelo, Seth M. Pollack, editors  2019 1
Spinal cord -- Tumors -- Immunotherapy   2
Immunotherapy -- Statistical methods : Bayesian adaptive design for immunotherapy and targeted therapy / Haitao Pan, Ying Yuan  2023 1
Immunotherapy -- Technological innovations : Nanoparticle-mediated immunotherapy / Tuan Vo-Dinh, editor  2021 1
Add Marked to Bag Add All On Page Add Marked to My Lists
Result Page   Prev Next